BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 29, 2007
View Archived Issues
Kosan, Roche End Partnership; Epothilone Goes Back Home
Kosan Biosciences Inc. and Roche Holding AG ended their five-year collaboration to develop and commercialize epothilones, anticancer agents that inhibit cell division. (BioWorld Today)
Read More
Biotech Allozyne Improving Protein Drugs With $30M Round
Read More
Jennerex Seeks Oncolytic Strait Between Scylla And Charybdis
Read More
Clinical Data IVD Asset Sale: $19.5M For Drug, Test Bids
Read More
NovaBay Prices IPO At $4/Share Gets $20M To Advance Pipeline
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Earnings Roundup
Read More
AACR Roundup
Read More